Key Takeaways
- CXMT’s shares closed at 49 yuan on July 27, a 466% increase from the IPO price, valuing the company at 3.3 trillion yuan.
- The IPO raised $8.6 billion, the largest in Asia in 2026, and CXMT surpassed ICBC as the most valuable China-listed firm.
- DeepSeek founder Liang Wenfeng’s hedge funds were among the top beneficiaries of the listing, per a Bloomberg report.
- CXMT held 7.67% of the global DRAM market in 2025, with Q1 2026 operating profit swinging from loss to 35.43 billion yuan.
- Analysts warn the memory cycle may be near a short-term peak, and US export controls continue to constrain CXMT’s technology access.
CXMT’s Stellar Debut Rewards DeepSeek’s Financial Backers
Hedge funds linked to DeepSeek founder Liang Wenfeng emerged as major winners in the initial public offering of CXMT, China’s leading DRAM maker, according to a report from Bloomberg. The stock closed at 49 yuan on July 27, 2026, a 466% jump from its 8.66 yuan IPO price on Shanghai’s STAR Market. The listing raised 57.92 billion yuan ($8.6 billion), making it Asia’s largest IPO of the year and valuing CXMT at roughly 3.3 trillion yuan ($487 billion) — enough to overtake Industrial and Commercial Bank of China as the country’s most valuable listed company.
Table of Contents
CXMT’s Market Breakthrough
Founded in 2016 in Hefei under chairman Zhu Yiming, CXMT has rapidly climbed the ranks of global memory chipmakers. According to its IPO prospectus, the company held a 7.67% share of the DRAM market in 2025, trailing only Samsung, SK Hynix, and Micron. In the first quarter of 2026, CXMT notched operating profit of 35.43 billion yuan, reversing a 2.83 billion yuan loss from a year earlier.
Revenue soared to 50.8 billion yuan ($7.5 billion) in the same period, a more than 700% year-on-year surge, as reported by NBC News. The company’s global shipment share of DRAM rose to approximately 9% in Q1 2026, up from 5% a year prior, per Counterpoint Research. Counterpoint forecasts CXMT could reach 11% share by 2028, though analysts say at least 15% is needed for long-term competitiveness against established rivals.
Apple’s Interest Highlights Growing Credibility
Apple has begun testing CXMT DRAM chips for devices sold in China, according to earlier reports. While still unverified at production scale, such trials signal potential validation of the company’s manufacturing quality. CXMT’s technology, however, still lags behind global leaders, a gap Morningstar analysts attribute to constraints imposed by US-led export controls that limit access to advanced chipmaking tools. This forces CXMT to rely on Chinese equipment suppliers, slowing its process node advancement.
Geopolitics and Competitive Dynamics
The CXMT IPO comes at a time when memory chips have become a focal point in US-China tech rivalry. The Pentagon has designated CXMT as having links to the Chinese military, and some US lawmakers have urged blocking American purchases of its chips, as NBC News reported. Despite these headwinds, CXMT is well-positioned to benefit from China’s push for semiconductor self-sufficiency, especially as AI becomes a national security priority, Morningstar noted.
The deep connection to AI is underscored by DeepSeek’s involvement. DeepSeek, a high-profile AI startup, relies on advanced compute infrastructure, and the founder’s hedge funds profiting from CXMT’s IPO highlights the symbiotic relationship between AI development and domestic chip manufacturing. Theodore Shou, an analyst cited by CNBC, observed that the stock’s surge was partly driven by limited free float and high market sentiment, but warned the memory cycle may be nearing a short-term peak.
Ivor Soans of Counterpoint Research told NBC News that CXMT’s DRAM market share could hit 11% by 2028, but cautioned that sustaining growth depends on navigating US export restrictions and closing the technology gap with Samsung and SK Hynix. The IPO followed SK Hynix’s $26.5 billion Nasdaq debut earlier in July, signaling robust investor appetite for memory chip equities.
The Road Ahead for China’s Chip Champion
CXMT’s record-breaking IPO marks a milestone not only for the company but for China’s ambitions in critical semiconductor segments. The windfall for DeepSeek’s financial backers, as Bloomberg reported, illustrates the growing interplay between AI startups and local chip suppliers. Yet, the company faces formidable challenges: the need to scale technology, overcome export controls, and navigate a fluctuating memory cycle. If CXMT can achieve the 15% market share analysts deem necessary, it could redefine the global DRAM landscape. For investors and industry watchers, the coming quarters will reveal whether the stock’s sprint is built on solid ground.
As the tech world watches China’s semiconductor trajectory unfold, staying informed is key. Andres SEO Expert offers programmatic SEO and AI automation services to help businesses scale their digital presence around breaking tech and market narratives. Connect with Andres or learn more about Andres SEO Expert to turn industry insights into actionable growth strategies.
Frequently Asked Questions
What is CXMT and why did its IPO make headlines?
CXMT is China’s leading DRAM manufacturer. Its July 2026 IPO on Shanghai’s STAR Market raised $8.6 billion, making it Asia’s largest IPO that year. The stock surged 466% on debut, valuing CXMT at roughly $487 billion, surpassing Industrial and Commercial Bank of China as the country’s most valuable listed company.
How did DeepSeek founder Liang Wenfeng benefit from CXMT’s IPO?
Hedge funds linked to DeepSeek founder Liang Wenfeng were major winners in CXMT’s IPO, profiting from the stock’s massive price jump. This highlights the symbiotic relationship between Chinese AI startups like DeepSeek and domestic chip manufacturers, as AI development relies on advanced compute infrastructure.
What is CXMT’s current market share in the global DRAM market?
According to its IPO prospectus, CXMT held 7.67% of the DRAM market in 2025, trailing Samsung, SK Hynix, and Micron. By Q1 2026, its global shipment share rose to approximately 9%. Counterpoint Research forecasts it could reach 11% by 2028, though analysts say at least 15% is needed for long-term competitiveness.
Why is Apple testing CXMT’s DRAM chips significant?
Apple has begun testing CXMT DRAM chips for devices sold in China, signaling potential validation of CXMT’s manufacturing quality. While not yet at production scale, such trials indicate growing credibility for CXMT as a supplier, even as its technology still lags behind global leaders due to US export controls.
What geopolitical challenges does CXMT face?
CXMT has been designated by the Pentagon as having links to the Chinese military, and some US lawmakers have urged blocking American purchases of its chips. US-led export controls limit CXMT’s access to advanced chipmaking tools, forcing it to rely on Chinese equipment suppliers, which slows its process node advancement.
What are the key risks and outlook for CXMT’s future growth?
CXMT must navigate US export restrictions, close the technology gap with Samsung and SK Hynix, and manage a fluctuating memory cycle. Analysts warn the memory cycle may be nearing a short-term peak. If CXMT can achieve the 15% market share considered necessary, it could redefine the global DRAM landscape.
